 
      Human Gene Therapy for Hemophilia
Docket Number: FDA 2018-D-2238 Issued by: Guidance Issuing Office Center for Biologics Evaluation and Research This guidance provides recommendations to sponsors developing human gene therapy (GT) products for the treatment of hemophilia including clinical …
 
       
       
       
       
       
       
       
       
       
       
       
       
  
 
     
     
     
     
     
     
     
     
     
     
     
     
    